Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Watermark Medical Signs Contract With Coventry Health Care

RELATED NEWS
Trade CA now with 

Watermark Medical, Inc., a privately held helthcare information technology company, announced that it has signed a contract with Coventry Health Care to provide home sleep testing service for the diagnosis of obstructive sleep apnea or OSA.

The company said the agreement expands Coventry's ability to deliver diagnostic testing to its members in a home-based environment while potentially reducing long-term costs.

Under the new multiyear agreement, Watermark will work directly with Coventry's physician network to diagnose members in the comfort and convenience of their own home at a fraction of the cost of a traditional in-lab sleep study.

Watermark stated that it will deliver these services through its Mail-to-Patient division, which supports physicians who do not currently provide home sleep diagnostics for their patients. Physicians in Coventry's network can refer patients with symptoms of OSA to Watermark, and the company will ship their diagnostic test directly to the patient.

Click here to receive FREE breaking news email alerts for CA Technologies and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.